MICHAEL NARACHI
CIK 1380022 · CEO & President · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$984.7K
Companies
4
Total Filings
46
Lifetime Open-Market Net
-$2.71M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RARE | Director | 40,441 | $24.35 | $984.7K | $0 | 13 | 2026-05-18 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | CEO & President | 8,356 | — | — | -$3.24M | 22 | 2017-10-17 |
| Eiger BioPharmaceuticals, Inc. (CLDN) Delisted | Director | 62,500 | — | — | $500.0K | 2 | 2015-06-05 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Director | 23,900 | — | — | $27.1K | 9 | 2013-05-24 |
Recent Filings · Page 5 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-01-26 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-10-08 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-04-02 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-12-22 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-08-07 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-11-29 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 41–46 of 46
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.